Currently, Eyenovia Inc [EYEN] is trading at $1.92, up 0.52%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EYEN shares have gain 6.67% over the last week, with a monthly amount drifted -63.58%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Eyenovia Inc [NASDAQ: EYEN] stock has seen the most recent analyst activity on November 18, 2024, when H.C. Wainwright downgraded its rating to a Neutral and also revised its price target to $2 from $12. Previously, Northland Capital started tracking the stock with Outperform rating on March 01, 2021, and set its price target to $10. On February 03, 2020, downgrade downgraded it’s rating to Perform.
This stock has fluctuated between a low of $1.73 and a high of $205.60 over the last 52 weeks. Eyenovia Inc [NASDAQ: EYEN] shares were valued at $1.92 at the most recent close of the market.
Analyzing the EYEN fundamentals
Trailing Twelve Months sales for Eyenovia Inc [NASDAQ:EYEN] were 0.03M which represents 35.64% growth. Gross Profit Margin for this corporation currently stands at -47.16% with Operating Profit Margin at -1091.78%, Pretax Profit Margin comes in at -1188.45%, and Net Profit Margin reading is -1188.45%. To continue investigating profitability, this company’s Return on Assets is posted at -1.66, Equity is -12.44 and Total Capital is -4.96. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8420 points at the first support level, and at 1.7639 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9761, and for the 2nd resistance point, it is at 2.0321.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Eyenovia Inc [NASDAQ:EYEN] is 0.71. As well, the Quick Ratio is 0.53, while the Cash Ratio is 0.46. Considering the valuation of this stock, the price to sales ratio is 134.40, the price to book ratio is 0.56.
Transactions by insiders
Recent insider trading involved Rowe Michael M, Chief Executive Officer, that happened on Aug 28 ’24 when 27071.0 shares were purchased. Chief Executive Officer, Rowe Michael M completed a deal on Aug 26 ’24 to buy 50000.0 shares. Meanwhile, 10% Owner Grant Stuart M. bought 1.52 million shares on Jul 02 ’24.
